Company Profiles

driven by the PitchBook Platform

Ventria Bioscience

Description

Developer of life-saving recombinant medicines designed to optimize the performance and eliminate animal components and blood products in biomanufacturing, cell-based vaccines, cellular therapy and regenerative medicine. The company's recombinant proteins and peptides includes new human therapeutic products and vaccines, derived from a plant-based manufacturing system, enabling healthcare providers to control and meet the medical needs in gastroenterology, hepatic and zoonotic disease and osteoporosis.

2001

Founded

PRIVATE

Status

11-50

Employees

Grant

Latest Deal Type

$731k

Latest Deal Amount

$10.5M

Total Amount Raised

Description

Developer of life-saving recombinant medicines designed to optimize the performance and eliminate animal components and blood products in biomanufacturing, cell-based vaccines, cellular therapy and regenerative medicine. The company's recombinant proteins and peptides includes new human therapeutic products and vaccines, derived from a plant-based manufacturing system, enabling healthcare providers to control and meet the medical needs in gastroenterology, hepatic and zoonotic disease and osteoporosis.

Website:

www.ventria.com

Ownership Status

Privately held (backing)

Financing Status

Venture Capital-Backed

Primary Industry

Pharmaceuticals

Other Industries

Biotechnology

Primary Office

PO Box 273330 Fort Collins, CO 80527United States +1 (970) 818-7010
Request a free trial to the PitchBook Platform
You're viewing a free company profile from the PitchBook Platform. To explore Ventria Bioscience's full profile, request a free trial.

Ventria Bioscience Valuation and Funding

Request access
Deal TypeDateAmountRaised to DatePost-ValStatusStage

Ventria Bioscience Investors (6)

Request access
Investor NameInvestor TypeHoldingInvestor SinceParticipating RoundsBoard
Seat
Contact
Info
Kansas Bioscience AuthorityGovernmentMinority000 0000000 0000
National Institute Of Allergy and Infectious Diseases Extramural ActivitesGovernment000 0000000 0000
National Institutes of HealthGovernment000 0000000 0000
U.S. Department of Health and Human ServicesGovernment000 0000000 0000
Vista VenturesVenture CapitalMinority000 0000000 0000
Kansas Bioscience Authority Government
National Institute Of Allergy and Infectious Diseases Extramural Activites Government
National Institutes of Health Government
U.S. Department of Health and Human Services Government
Vista Ventures Venture Capital

Ventria Bioscience Executive Team (9)

NameTitleBoard
Seat
Contact
Info
Scott DeeterPresident, Chief Executive Officer & Board Member
Steve Pettit Ph.DDirector, Cell Culture Development
Angus ConnellDirector, Operations
Patrick SmithDirector, Quality Assurance
William RutterChairman & Co-Founder
Scott Deeter President, Chief Executive Officer & Board Member
Steve Pettit Ph.D Director, Cell Culture Development
Angus Connell Director, Operations
Patrick Smith Director, Quality Assurance
William Rutter Chairman & Co-Founder

Ventria Bioscience Board Members (10)

NameRepresentingRoleSinceContact
Info
David Dwyer JDVista VenturesGeneral Partner & Co-Founder000 0000
Dominique BalySelfBoard Member000 0000
Hugh ReinhoffSelfBoard Observer000 0000
Melvin BoothSelfBoard Member000 0000
Pablo Valenzuela Ph.DSelfBoard Member000 0000
David Dwyer JD General Partner & Co-Founder Vista Ventures
Dominique Baly Board Member Self
Hugh Reinhoff Board Observer Self
Melvin Booth Board Member Self
Pablo Valenzuela Ph.D Board Member Self
Request full access to PitchBook